Viking Therapeutics (VKTX) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Viking Therapeutics (VKTX) over the last 12 years, with Q4 2025 value amounting to -$157.7 million.
- Viking Therapeutics' Profit After Tax fell 34515.91% to -$157.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$359.6 million, marking a year-over-year decrease of 22705.46%. This contributed to the annual value of -$359.6 million for FY2025, which is 22705.46% down from last year.
- As of Q4 2025, Viking Therapeutics' Profit After Tax stood at -$157.7 million, which was down 34515.91% from -$90.8 million recorded in Q3 2025.
- Over the past 5 years, Viking Therapeutics' Profit After Tax peaked at -$12.4 million during Q4 2021, and registered a low of -$157.7 million during Q4 2025.
- Its 5-year average for Profit After Tax is -$34.0 million, with a median of -$20.9 million in 2022.
- Its Profit After Tax has fluctuated over the past 5 years, first crashed by 1028.57% in 2023, then crashed by 34515.91% in 2025.
- Over the past 5 years, Viking Therapeutics' Profit After Tax (Quarter) stood at -$12.4 million in 2021, then tumbled by 58.3% to -$19.6 million in 2022, then dropped by 25.8% to -$24.6 million in 2023, then crashed by 43.94% to -$35.4 million in 2024, then crashed by 345.16% to -$157.7 million in 2025.
- Its Profit After Tax was -$157.7 million in Q4 2025, compared to -$90.8 million in Q3 2025 and -$65.6 million in Q2 2025.